INTRODUCTION
The Epstein-Barr virus (EBV), a human herpesvirus causing infectious mononucleosis as a primary disease, is an ubiquitous pathogen. Lifelong persistence in B lymphocytes is under control of the immune sys tern; however, chronic active progression of an acute infection or of neoplasias, like Burkitt's lymphoma or nasopharyngeal carcinoma, can develop in certain circumstances . Lymphoid cells are far from being the only site for EBV replication and a tissue-specific virus/host interaction is a central feature of EBV pathobiology (Wolf et al., 1984) . At present, epithelial tissue appears to be a site of viral persistence and a source of virus production. Regulation of viral replication is dependent on the differentiation of its host cells (Becker et a/., 1989) . EBV regulation is characterized by latency and the cascade of the lytic cycle of replication, comparable to several other herpesvirus systems, such as herpes simplex virus (Roizman and Batterson, 1985) or Herpesvirus saimiri (Hell et a/., 1985) .
Lytic activation is based on the induction of trans-acting, nuclear proteins (Chevallier-Greco er a/., 1986; Countryman et a/., 1987; Hardwick eta/., 1988; Liebermann et a/., 1986; Marschall et a/., 1989a) belonging to the immediate early regulatory class (Biggin et a/., 1987) . RNA analysis by our group suggested an addi- ' To whom reprint requests should be addressed. tional transcript, which appeared to be independent of prior synthesis of viral proteins and maps in the EBV BarnHI I' section . In this work we characterize the Epstein-Barr virus BI'LF4 trans-activator, designated I'ta. Gene functions including promoter activity, protein synthesis in bacteria and cell systems, transacting properties, and autoregulation are described. We established a dynamic model system using a secreted reporter product to prove the transcriptional dependence of this gene on the proceeding differentiation of the host cell. A specific differentiated stage emerges to play a key role in the lytic cycle of EBV. In epithelial cells, the I'ta gene was shown to be inducible and functional.
In lymphoid cells, deletion of this lytic regulator seems to be tolerable under favorable conditions, but this deletion was shown to be rather exceptional in natural isolates.
MATERIALS AND METHODS

Plasmid constructions
The coding sequence of the open reading frame (ORF) BI'LF4 was derived from cm 302-21 cosmid DNA (Polack et a/., 1984) using the restriction sites of SalI and BarnHI (1390-bp fragment). For the construction of pSVI', regulatory elements of the simian virus 40 (SV40) (early promoter/enhancer as 830-bp Taql-Srul fragment and splice/polyadenylation signals as 1640-bp Ncol-Pstl fragment) were excised from the original pSV2CAT construction (Gorman et a/., 1982) . As shown in Fig. 1 B these fragments were inserted into plin vectors, derived from pUC by insertion of new synthetic polylinkers (Max von Pettenkofer-Institute, Munich). In pSCI', the TATA box of the SV40 early promoter was replaced by the human cytomegalovirus (HCMV) immediate early promoter/enhancer (NcolSa/l insertion of the subcloned HCMV sequence as described below) to optimize expression. For bacterial protein synthesis, the ORF BI'LF4 was positioned under the control of either the hybrid trpllac promoter in vector pTrc99A (Amann et a/., 1988) (Fig. 1 B) or the combined phage T7 promoter (Al)//ac operator in vector pUHE24-2 (Bujard et al., 1987) . The I'ta promoter element, an 890-bp Alul-Alul fragment, subcloned from H3-Dl cosmid DNA (Polack et a/., 1984) , was inserted into reporter gene constructs using the coding sequence for either CAT or HBsAg as a reporter element. Cloning strategies for all EBV promoter regions and reporter constructions were described in detail previously (Marschall et al., 198913) . For controls, the HCMV immediate early promoter/enhancer (770-bp HindIll-Hpall fragment) (Boshat-t et a/., 1985) was subcloned into pUC18, cut by HindIll and Accl, and subsequently inserted upstream from the reporter sequences generating pCMVHBs and pCMVCAT. In the BZLFl expression vector pCMVZ (including two spliced exons at the 3'-end) this HCMV element was used to promote transcription of the genomic BarnHI Z sequence (1065-bp Nael-Ncol fragment) (Skare et al., 1980) . Cell culture, transfections, and induced differentiation HeLa, COS-1, and mouse teratocarcinoma F9 cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% (v/v) fetal calf serum, 100 units/ml of penicillin, and 250 Fg/ml of streptomycin. Eight hours before transfection, the cells were seeded at a density of lO?lOO-mm petri dish. The cells were transfected by the CaHPO, method (McCutchan et al., 1968 ) with 10 to 40 pg of DNA, using vector DNA to achieve equimolar concentrations in separate tests. The CaHPO,-DNA precipitate was removed 4 to 8 hr after addition and the cells were grown in fresh medium. TPA (tumor promoting agent, phorbol-12-myristate-13-acetate) was added to a final concentration of 20 r-&I. Cell differentiation of the F9 line was induced by treatment with 1 PLM retinoic acid for at least 4 days. Spontaneously growing B-cell lines were cultured from EBV-positive peripheral blood lymphocytes. Two weeks after isolation of the lymphocytes by centrifugation in Ficoll-metrizoate gradients (density 1.077) cyclosporin A was added at a concentration of 1 pg/ml to suppress T-cell growth, and the medium was exchanged once a week. Within 4 to 6 weeks spontaneous growth of EBV-positive B cell populations was observed.
HBsAg reporter system and CAT assay
The HBsAg reporter system is based on the secretion of HBsAg (missing pre-S sequences) into the culture supernatant and its quantification correlating to the tested promoter activity (Marschall et a/., 1989b) .
HBsAg production was assayed in supernatant aliquots by the commercially available, quantitative radioimmunoassay for HBsAg (Abbott). Since cell lysis was not required, transfection assays could be continuously monitored over a period of time. For CAT assays, the cells were washed in phosphate-buffered saline (PBS) 2 days post-transfection and lysed by sonication in 100 ~1 of 0.25 11/1Tris-HCI, pH 8.0, on ice. Cell debris was removed by centrifugation for 5 min at 500 g. The protein concentrations were equilibrated after measurement of the optical densities at 260 and 280 nm. The protein extract (50 ~1) was mixed with a reaction mixture containing 100 ~1 of 0.25 1\/1 Tris-HCI (pH 8.0) 20 ~1 of 4 mM acetyl coenzyme A (Pharmacia-LKB), and 10 ~1 of [14C]chloramphenicol (0.25 &i, Amersham) and incubated for 1 hr at 37°C. Chloramphenicol and its acetylated products were extracted with 400 PI of ethyl acetate and evaporated in a speed-vacuum centrifuge. Dried samples were resuspended in 10 ~1 of ethyl acetate and spotted on silica gel thinlayer chromatography plates (Merck 5737) in chloroform:methanol (95:5) solvent. The plates were exposed on hyperfilm-@max (Amersham) for 12 to 24 hr.
Western blot and immunofluorescence
For Western blots, bacterial protein extracts were prepared from exponentially growing transformed fscherichia co/i clones. Protein synthesis was induced by addition of 2 mn/r isopropyl-/3-o-thiogalactopyranoside for at least 2 hr. Lysates were prepared in 2Ob sodium dodecyl sulfate (SDS) by sonication. Standard immunoblotting and modified staining procedures were described previously (Marschall et al., 1989a) .
For indirect immunofluorescence, transfected cells (2 days post-transfection) were fixed in ice-cold acetone for 5 min. Human antisera and fluorescein isothiocyanate-linked goat anti-human antibodies (Medac) were applied 1:50 for 1 hr at 37°C. After the cells were washed with PBS, the slides were evaluated at a microscope magnification of 250.
Southern blot
For Southern blots, 10 pg of total cell DNA was digested with Sstl restriction enzyme and separated in 1.5% (w/v) agarose gels. The DNA transfer onto nylon membranes was achieved by suction through Whatman filters in 20X SSC buffer (3 IVI NaCI, 0.3 M Na citrate) for 8 hr. Crosslinking was done by a 5-min exposure to ultraviolet light. Hybridization of the blots was performed as described in detail by Boehringer Mannheim, "DNA Labeling and Detection Kit, Nonradioactive."
As BI'LF4-specific probe, a 1 .O-kb Sstl fragment was isolated from the Sstl digest of pSVI'. The nonradioactive labeling with digoxigenin (DigdUTP) was again done following the instruction mentioned above.
RESULTS
Genome localization and subcloning
The ORF BI'LF4 is located in the BamHl I' region of the Raji genome, starting with the ATG codon at position 141 15 (paul.sin-sequence, kindly offered by Paul Farrell) (Baer et al., 1984; Farrell et al., 1987; Hatfull et al., 1988) . Sequence analysis identified conserved promoter motifs, e.g., TATA box, a cryptic CAAT signal (position -75), and a perfect AP-1 binding site (position -450) (Angel et a/., 1987) . As the BamHl I' fragment is partly deleted in the B95-8 standard genome (Fig. 1 A) , all subclones were constructed using M-ABA strain DNA (Polack et a/., 1984) .
In the eucaryotic expression vectors pSVl'and pSCI', the ORF BI'LF4 was expressed under the control of heterologous promoters and terminated by the simian virus 40 polyadenylation signal. Efficient RNA transport was achieved by the insertion of the SV40 splice acceptor and donor. In pSCI', the coding sequence was controlled by a strong hybrid promoter (SV40 early enhancer plus HCMV immediate early promoter/enhancer). Two vectors with different promoter/operator systems were used for the I'ta protein synthesis in E. co/i, pTrcl' (Fig. 1 B) and pUHI'(see Materials and Methods). The I'ta promoter was analyzed using the reporter plasmids pl'CAT and pl'HBs.
Vans-Activity and autoregulation trans-Regulatory functions of the I'ta product were tested in cotransfection assays. Reporter plasmids with selected promoters were analyzed for increased activity as a consequence of I'ta expression ( Fig. 2A) . No effect was seen on heterologous targets, such as the SV40 early promoter/enhancer (pSVCAT) and the HCMV immediate early promoter/enhancer (pCMVCAT). Using a reporter construction with the SV40 early promoter, lacking the 72-bp enhancer repeats (p21CAT not shown), the basal level of expression was reduced to where no responsiveness to I'ta was detected. Several EBV promoters of different regulatory classes, e.g., immediate early (pZCAT, pRCAT), early (pACAT), and latent (pNCAT), were likewise not activated. A specific trans-activation, however, was shown for two test constructions of the EBV early MS promoter (pS1 CAT: 127-bp basic promoter, pSCAT: 1.4-kb upstream element plus basic promoter) and for the I'ta promoter itself (pl'CAT). The strong influence on the proximal part of the MS promoter was studied in detail under concentration-dependent test conditions using the HBsAg (hepatitis B virus surface antigen) reporter system (Fig. 3A) . Autoactivation of the I'ta promoter by its own gene product could be intensified with the efficient expression vector pSCI' (Fig. 2B ).
Cell differentiation and promoter stimulation
The mouse teratocarcinoma line F9 was used as a cell system for inducible differentiation by retinoic acid (Umesono et al., 1988) . Coactivation of different EBV promoters by differentiation-dependent cellular regulators was studied in the absence of viral proteins. Most of the EBV target promoters did not respond to changes in the differentiation stage and growth behavior, while the I'ta promoter and the distal segment of the MS promoter were clearly activated in retinoic acid-treated cells (Fig. 3B) . Induction of other constructs with very low basal activity was likewise not detected in independent assays, even after attempts to enrich the reporter protein particles by ultracentrifugation.
Two further effects of influencing the activity of the I'ta promoter were tested. Since the regulatory upstream sequence contains an AP-1 consensus binding site, high promoter activity was assumed to be induced by TPA incubation (Lee et al., 1987) or by expression of Zta Urier et al., 1989) . Our findings indicate that both pathways of activation stimulate the I'ta promoter to a certain extent (Fig. 2B) , but to a level much lower than that observed for autostimulation. We propose therefore that mainly cellular differentiation triggers the synthesis of the I'ta protein, which subsequently accelerates its own expression.
Expression and nuclear localization
Using procaryotic in-frame vectors, the ORF BI'LF4 was expressed as an authentic viral protein without heterologous carboxy-terminal fusion (Fig. 4A) . Dependent on reliable promoter/operator systems, the polypeptide was stably expressed in E. co/i in amounts sufficient for further characterization. We determined a molecular weight of 48 kDa, which was in line with the are marked by vertical arrows and angles, respectively. Procaryotic elements of pTrcf'are abbreviated as ori (origin of replication), ApR (ampicillin resistance), lac 1' (repressor allele), and P,, (inducible hybrid promoter). The test constructions for the I'ta promoter, pl'HBs and pl'CAT, contain the coding sequences for the hepatitis B virus surface antigen (HBsAg) or chloramphenicol acetyltransferase (CAT) as reporters. Restriction enzymes: A, Accl; A', AU; B, BarnHI; B', Bglll; E, EcoRI; H, HindIll; H'. Hincll; H', Hpall; N, Ncol; P, Pstl; S, Sall; S', Sstl; S2, Smal; S3, Stul; T, Taql; X, Xbal sequence prediction. High titers of I'ta-specific antibodies in human sera, derived from patients with nasopharyngeal carcinoma, indicate the relevance of the gene product during natural infection.
Expression of I'ta in transfected eucaryotic cells was analyzed by immunofluorescence.
A small percentage (2-5%) of transfected cells showed a bright, mostly nuclear fluorescence when incubated with human antisera. Most of the positive ceils showed a nuclear staining (Fig. 4B) . Mock-transfected cells and EBVnegative sera (preabsorbed with a mix of E. co/i and BJA-B cell extracts, respectively) were used in control experiments and did not give positive signals.
Presence in individual EBV isolates
We tested the presence of the ORF BI'LF4 on DNA level by Southern blot analysis (Fig. 5) . Several established EBV-positive and -negative Burkitt lymphoma lines were compared to spontaneously growing B cells of seven EBV-positive persons. The BI'LF4-specific 1 .O-kb Sstl fragment, originally subcloned from the M-ABA type, was found in all individual isolates in its unaltered molecular size. The Raji and the PSHR-1 strain were used as positive controls. Both Sstl recognition sequences were conserved in all EBV types tested. As expected, no BI'LF4 signal was detected in DNA from EBV-negative cells and in the mutant B95-8 strain.
DISCUSSION
The most important interpretations of our observations are the following: (i) the EBV genome encodes a trans-acting factor in the ORF BI'LF4; (ii) this factor has strong and specific regulatory effects but can be dis- pensed in vitro at least in lymphoid cells, where a moderate lytic cycle of EBV in marmoset-derived B95-8 cells is observed; (iii) its promoter is regulated by cellular factors and by its own gene product; (iv) the I'ta activity is not restricted to lymphoid cells and is influenced by the differentiation stage of the host cell; (v) the gene product is a 48-kDa protein which is transported into the nucleus; and (vi) the gene is present in individual EBV isolates, indicating its general importance in natural infection.
We characterized a 48-kDa EBV gene product which is mapping in the BarnHI I' region of EBV but is deleted in the B95-8 cell-derived EBV genome. Recent transcript analyses proved the affiliation of I'ta to the immediate early regulatory class. Studies in freshly infected or superinfected B-cell lines, in the presence of translation inhibitors, delineated that l'ta is an immediate early gene because its expression does not depend on prior protein synthesis (U. Leser, 1990 , Ph. D. thesis, University of Munich, FRG; U. Leser, manuscript in preparation). Parallel to the two other immediate early factors of EBV, BZLFl (EBI ; Chevallier-Greco eta/., 1986) (ZE-BRA; Countryman et a/., 1987) (Zta; Cox et a/., 1990) and BRLFl (R; Hardwick et a/., 1988) (Rta; Cox et al., 1990) , l'ta activates the early antigen level by turning on the BMLFl/BSLF2
gene. The promoter of this universal, post-transcriptional MS regulator (Buisson er al., 1989; Kenney et al., 1989a; Kenney et al., 198913 ) was characterized as a target for different pathways following the lytic switch (Marschall et a/., in press) .
Although the regulatory properties of the I'ta product are proven, its role in the lytic cascade can obviously be substituted. This situation is in line with the regulation of herpes simplex virus, where the powerful ICPO trans-activator is not essential for the viral cycle (Sandri-Goldin et al., 1987) . In context with the central role of nonlymphoid, in particular differentiating epithelial cells in the life cycle of EBV (Becker eta/., 1989; Wolf et a/., 1984 ) the responsiveness of the I'ta promoter to differentiation-dependent host factors may play a key role in the biology of EBV. Although mouse cells, as used in our model system, are unlikely to support either latent or lytic EBV replication, our results clearly show the responsiveness of distinct EBV promoter elements to cellular factors with transient activity. Morphological change in the differentiating cells was correlated to the induction of the I'ta promoter independent from EBV.
The fact that the gene is deleted in the viral genome of the B95-8 line, extensively passaged in nonnatural marmoset lymphocytes, suggests selective pressure against efficient virus replication for the benefit of the host cells. In viva the selective pressure apparently is reversed in favor of the most active viruses, as this deletion was never found in recently established cell lines and only once in a cell culture with an extensive history of viral propagation (Shope et al., 1973) .
The finding that complex viruses have alternate, partly redundant genes sheds new light on cell typespecific regulation. Activation of the I'ta product might explain the high efficiency of lytic EBV expression in epithelial cells (seen in the tonsils during infectious mononucleosis, in the parotid gland of all seropositives, and in the hairy leukoplakia lesions of AIDS patients). Viruses will frequently not replicate in unre- 10 ml of the culture supernatant was assayed in each case. Panel B shows HBsAg reporter expression in F9 cells, without retinoic acid treatment (row A) or with retinoic acid treatment (row B). Each left value (a) reflects the promoter activity of the first 2 days and each right value (b) of the following 2 days posttransfection. The target promoters used are described in Fig. 2 (1, pZHBs; 2, pRHBs; 3, pSHBs; 4, pS1HBs; 5, pl'HBs; 6, pAHBs; 7, pNHBs). placeable, undifferentiated cells but will replicate in differentiated epithelium, often localized on outer surfaces. Supply of such cells is limited and selfrenewing. Similar concepts can be seen for papilloma viruses.
An interesting feature of the I'ta gene is the positive feedback effect on its own promoter. This is in contrast to reports on immediate early genes of herpes simplex virus which seem to limit their gene expression by down-regulation of their own promoters (O'Hare era/., 1987). Such an autorepression has not been found so far within the EBV system. However, alternative ways of positive regulation were detected (moderate responsiveness to TPA, Zta; consensus AP-1 binding site), although their relevance in the lytic cycle still awaits further experimental data.
The nucieotide sequence of the l'ta gene was compared with those of well-characterized viral or cellular regulatory genes, such as the coding regions for EBV Zta and Rta, for human c-fos and c-jun, for human immunodeficiency virus 1 tat, human adenovirus 4 El A, human cytomegalovirus immediate early 1, herpes simplex virus 1 ICP 0, pseudorabies virus 180-kDa protein, and hepatitis B virus X gene, using GCG software (1, pTrc99A; 2, pTrcl'; 3, pTrcl' Induced; 4, 5, pUHI'; 6, pUHI'induced) were incubated with a human serum pool (nasopharyngeal carcinoma patients) and stained in alkaline phosphatase procedures. The molecular size was determined by comparison with a protein standard (Sigma; 116, 97.4, 66, 45, and 29 kDa) . lmmunofluorescence staining of transfected cells (1 to 3. pSVI'; 4 to 5, pSCI') with a human serum pool shows the nuclear localization of the l'ta protein in adherent HeLa (1 to 4) and trypsinized COS-1 cells (5). (Devereux, Haeberli and Smithies; Wisconsin). However, no stringent homologies, e.g., in DNA binding regions or protein complexing domains, were detected.
Some interesting questions remain to be answered. For example, is the I'ta activity in vivo dependent on the cell type? Obviously in lymphocytes, deletion of I'ta moderates the EBV phenotype with respect to the lytic activity. One might speculate that complementation with I'ta might increase the efficiency of the Iytic gene expression in 895-8 cells, comparable to the EBV regulation in the high producer strain P3HR-1. In the P3HR-1 strain, an elevated amount of Zta, derived from the WZhet DNA (Rooney et al., 1988) , constitutively promotes the lytic cycle. Alternatively I'ta could be a function required primarily in nonlymphoid target cells as mentioned above.
In addition to its role in the Iytic infection, one would have to consider possible other functions, e.g., in cell transformation via interaction with cell proliferation, as has been shown for the tax gene of the human T lymphotropic virus-l (Leung et a/., 1988) . It may also play a role in EBV immunology. Cytotoxic T-cell responses against immediate early proteins, as studied in detail for other herpesvirus systems (Reddehase et a/., 1989) , have been involved in control of EBV infection of humans as well (Jilg et al., 1989) .
